Skip to main content
Log in

Gain-switched 311-nm Ti:Sapphire laser might be a potential treatment modality for atopic dermatitis

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Phototherapy with 311-nm narrowband-UVB (NBUVB) is an effective adjuvant treatment modality for atopic dermatitis (AD). In this study, we evaluated the therapeutic effect of the newly developed gain-switched 311-nm Ti:Sapphire laser device using a NC/Nga mouse AD model. A total number of 50 mice were used in this study. Atopic dermatitis (AD) was induced in mice by exposure to Dermatophagoides farina. These, NC/Nga mice were then treated with conventional 311-nm NBUVB or the newly developed gain-switched 311-nm Ti:Sapphire laser. The clinical features, dermatitis severity scores, and scratching behavior were assessed. In addition, serologic analyses including inflammatory cytokines and histological analyses were performed. Gain-switched 311-nm Ti:Sapphire laser improved the AD-like skin lesions, severity, and symptoms of AD in the NC/Nga mouse model. This new laser also modulated the immune response found in the AD model, including hyper-IgE, upregulated Th2 cytokines, and the Th2-mediated allergic inflammatory reaction. Gain-switched 311-nm Ti:Sapphire laser shows therapeutic promise via an immune-modulation mechanism in an AD mouse model. These data suggest that gain-switched 311-nm Ti:Sapphire laser may be useful as a targeted phototherapy modality for AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA (2009) Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 129:14–30

    Article  PubMed  Google Scholar 

  2. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K et al (2014) Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 71:116–132

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 26:1045–1060

    Article  CAS  PubMed  Google Scholar 

  4. Denby KS, Beck LA (2012) Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol 12:421–426

    Article  CAS  PubMed  Google Scholar 

  5. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol 26:1176–1193

    Article  CAS  PubMed  Google Scholar 

  6. Jekler J, Larkö O (1988) UVB phototherapy of atopic dermatitis. Br J Dermatol 119:697–705

    Article  CAS  PubMed  Google Scholar 

  7. Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A (2000) Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 142:39–43

    Article  CAS  PubMed  Google Scholar 

  8. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM (2001) Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 357:2012–2016

    Article  CAS  PubMed  Google Scholar 

  9. Legat FJ, Hofer A, Brabek E, Quehenberger F, Kerl H, Wolf P (2003) Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 139:223–224

    Article  PubMed  Google Scholar 

  10. Anderson TF, Waldinger TP, Voorhees JJ (1984) UV-B phototherapy. An overview. Arch Dermatol 120:1502–1507

    Article  CAS  PubMed  Google Scholar 

  11. Baltás E, Csoma Z, Bodai L, Ignácz F, Dobozy A, Kemény L (2006) Treatment of atopic dermatitis with the xenon chloride excimer laser. J Eur Acad Dermatol Venereol 20:657–660

    Article  PubMed  Google Scholar 

  12. Tarasov A, Chu H (2015) Solid-state laser wavelength selection and tuning by fused-silica-transmission gratings with subwavelength deep-surface relief. Opt Lett 40:3572–3575

    Article  PubMed  Google Scholar 

  13. Matsuoka H, Maki N, Yoshida S, Arai M, Wang J, Oikawa Y et al (2003) A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 58:139–145

    Article  CAS  PubMed  Google Scholar 

  14. Inoue T, Sugimoto M, Sakurai T, Saito R, Futaki N, Hashimoto Y et al (2007) Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA. J Gene Med 9:994–1001

    Article  CAS  PubMed  Google Scholar 

  15. Kwon TR, Mun SK, Oh CT, Hong H, Choi YS, Kim BJ, Kim BJ (2014) Therapeutic effects of full spectrum light on the development of atopic dermatitis-like lesions in NC/Nga mice. Photochem Photobiol 90:1160–1169

    CAS  PubMed  Google Scholar 

  16. Simon JC, Pfieger D, Schöpf E (2000) Recent advances in phototherapy. Eur J Dermatol 10:642–645

    CAS  PubMed  Google Scholar 

  17. Tarasov A, Chu H (2015) Solid-state laser wavelength selection and tuning by fused-silica-transmission gratings with subwavelength deep-surface relief. Opt Lett 40(15):3572–3575

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beom Joon Kim.

Ethics declarations

Funding sources

None

Conflict of interest

None declared

Additional information

Sun Young Choi and Chang Taek OH contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, S.Y., OH, C.T., Kwon, TR. et al. Gain-switched 311-nm Ti:Sapphire laser might be a potential treatment modality for atopic dermatitis. Lasers Med Sci 31, 1437–1445 (2016). https://doi.org/10.1007/s10103-016-2006-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-016-2006-8

Keywords

Navigation